Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Vaccine-mediated protection against Merbecovirus and Sarbecovirus challenge in mice

Cell Reports(2023)10.1016/j.celrep.2023.113248Source: DataRank Database

Vaccine-mediated protection against Merbecovirus and Sarbecovirus challenge in mice is a research paper published in Cell Reports (2023). On theSindex it has a DataRank of 0. It has been cited 22 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access22 citations

Download PDF

Cite:

Linked data & code

rrid

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (10 grants)OA: goldTopics (29)IDs (PubMed, PMC)Annotations (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (23)

Alexandra Schäfer,Tyler D. Gavitt ORCID,Michael L. Mallory ORCID,Esther Lee ORCID,Nicholas J. Catanzaro

Live enrichment

PubMed:37858337 PMC:PMC10842144

U.S. Department of Health and Human Services

Grant: HHSN272201700036I

U.S. Department of Health and Human Services

Grant: P01 AI158571

U.S. Department of Health and Human Services

Grant: U54 CA260543

NIAID NIH HHS

Grant: HHSN272201700035I

National Institutes of Health

Grant: 4U54CA260543-02

North Carolina Seronet Center for Excellence

National Institutes of Health

Grant: 1P01AI158571-01A1

Design and Development of a Pan-betacoronavirus Vaccine

National Institutes of Health

Howard Hughes Medical Institute

Takeda Pharmaceuticals U.S.A.

National Institute of Allergy and Infectious Diseases

goldLicense: CC BY NC ND

publisherhttps://api.elsevier.com/content/article/PII:S2211124723012603?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2211124723012603?httpAccept=text/plain

Europe_PMChttps://europepmc.org/articles/PMC10842144

Europe_PMChttps://europepmc.org/articles/PMC10842144?pdf=render

https://doi.org/10.1016/j.celrep.2023.113248

Fields of Study

0301 basic medicine03 medical and health sciences

MeSH Terms

AnimalsHumansMiceAntibodies, ViralAntibodies, NeutralizingMiddle East Respiratory Syndrome CoronavirusSARS-CoV-2COVID-19 VaccinesSevere acute respiratory syndrome-related coronavirus

Keywords

NanoparticleSARS-CovNeutralizationUniversal vaccineReceptor-binding domainMers-covBat CoronavirusSars-cov-2Cp: ImmunologyMiceCOVID-19 VaccinesSevere acute respiratory syndrome-related coronavirusMiddle East Respiratory Syndrome CoronavirusAnimalsHumansAntibodies, ViralAntibodies, NeutralizingArticle

Vaccine-mediated protection against Merbecovirus and Sarbecovirus challenge in mice

FAIR Checklist

Authors (23)

Funding (10 grants)

Open Access

Topics

Annotations (Europe PMC)